Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuning Le

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Cancers|June 10, 2023
New Actions on Actionable Mutations in Lung CancersXiuning Le, Yasir Y Elamin, Jianjun Zhang
Journal of Thoracic Disease|December 10, 2017
Moving more potent and less toxic options to the frontline in the management of advanced lung cancerXiuning Le, Deepa Rangachari, Daniel B Costa
Expert Review of Anticancer Therapy|March 5, 2016
The safety and efficacy of osimertinib for the treatment of EGFR T790M mutation positive non-small-cell lung cancerXin Gao, Xiuning Le, Daniel B Costa
The New England Journal of Medicine|March 26, 2026
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer. ReplyXiuning Le, Jan Christoph Brase, Weichao Bao
Therapeutic Advances in Medical Oncology|March 23, 2023
Efficacy of immunotherapy in oncogene-driven non-small-cell lung cancerNatalie I Vokes, Kelsey Pan, Xiuning Le
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|December 13, 2019
β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-BlockersMonique B Nilsson, Xiuning Le, John V Heymach
Cancers|February 11, 2023
MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and OpportunitiesKang Qin, Lingzhi Hong, Jianjun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2024
PIKing up and AKTing on Resistance Mutations in Osimertinib-Treated EGFR-Mutated NSCLCNatalie I Vokes, Xiuning Le, Timothy A Yap
Therapeutic Advances in Medical Oncology|March 1, 2021
Current and future treatment options for <i>MET</i> exon 14 skipping alterations in non-small cell lung cancerLingzhi Hong, Jianjun Zhang, John V Heymach, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Evolving Role of Immunotherapy in Recurrent Metastatic Head and Neck CancerXiuning Le, Renata Ferrarotto, Trisha Wise-Draper, et al.
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Cancers|June 10, 2023
New Actions on Actionable Mutations in Lung CancersXiuning Le, Yasir Y Elamin, Jianjun Zhang
Journal of Thoracic Disease|December 10, 2017
Moving more potent and less toxic options to the frontline in the management of advanced lung cancerXiuning Le, Deepa Rangachari, Daniel B Costa
Expert Review of Anticancer Therapy|March 5, 2016
The safety and efficacy of osimertinib for the treatment of EGFR T790M mutation positive non-small-cell lung cancerXin Gao, Xiuning Le, Daniel B Costa
The New England Journal of Medicine|March 26, 2026
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer. ReplyXiuning Le, Jan Christoph Brase, Weichao Bao
Therapeutic Advances in Medical Oncology|March 23, 2023
Efficacy of immunotherapy in oncogene-driven non-small-cell lung cancerNatalie I Vokes, Kelsey Pan, Xiuning Le
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|December 13, 2019
β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-BlockersMonique B Nilsson, Xiuning Le, John V Heymach
Cancers|February 11, 2023
MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and OpportunitiesKang Qin, Lingzhi Hong, Jianjun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2024
PIKing up and AKTing on Resistance Mutations in Osimertinib-Treated EGFR-Mutated NSCLCNatalie I Vokes, Xiuning Le, Timothy A Yap
Therapeutic Advances in Medical Oncology|March 1, 2021
Current and future treatment options for <i>MET</i> exon 14 skipping alterations in non-small cell lung cancerLingzhi Hong, Jianjun Zhang, John V Heymach, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Evolving Role of Immunotherapy in Recurrent Metastatic Head and Neck CancerXiuning Le, Renata Ferrarotto, Trisha Wise-Draper, et al.
Pageof 18